Manufacturer record
Navkar Lifesciences WHO-GMP Certified Company: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Navkar Lifesciences WHO-GMP Certified Company (Himachal Pradesh) were declared Not of Standard Quality between August 2022 and August 2022. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Navkar Lifesciences WHO-GMP Certified Company in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ursodeoxycholic Acid Tablets IP 300 mg (BAKLIV-300 TABLETS) | TF2037AMfg 2022-06 · Exp 2024-05 | Identification A, Identification B and AssayAssay | RDTL ChandigarhCDSCO lab | Aug 2022 |
| Mefenamic Acid and Paracetamol Tablets (MEFIGESIC FORTE TABLETS) | TD2030BMfg 2022-04 · Exp 2024-03 | Assay of Mefenamic AcidAssay | RDTL ChandigarhCDSCO lab | Aug 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.